RECRUITING

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this randomized clinical trial it to test the efficacy of CuidaTEXT, the first Alzheimer's disease and Related Dementias (ADRD) caregiver support intervention to capitalize on text messaging, among Latinos. Researchers will compare those who receive the CuidaTEXT intervention to those who do not receive the intervention to see if CuidaTEXT effects Latino caregiver stressors and their negative consequences . Participants will receive a variety of text messages, from automatic to keyword-drive, regarding ADRD education, social support, self-care, ADRD care management, and behavioral symptoms. Participants will also complete measures regarding depressive symptoms, coping, behavioral symptoms, and preparedness for caregiving.

Official Title

Testing the Effects of a Text Message Caregiver Support Intervention for Latinos

Quick Facts

Study Start:2025-02-17
Study Completion:2029-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06728436

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Over the age of 18
  2. * Spanish and English-speaking people who identify as Latino
  3. * Reports providing hands-on care for a relative who has been given a clinical or research ADRD diagnosis and has an Eight-item Informant Interview to Differentiate Aging and Dementia (AD-8) screening score ≥2, indicating cognitive impairment
  4. * Has a score of 7 or higher on the 10-item Center for Epidemiologic Studies Depression Scale (CESD-10)
  5. * Self-reports being able to read and write
  6. * Owns a cell phone with a flat fee, and uses it at least weekly for texting.
  1. * Participation in another wellbeing-related clinical trial
  2. * Cohabitation with another participant in the CuidaTEXT R01 Study
  3. * Participants who provide care for a person with ADRD already cared for by another participant in the CuidaTEXT R01 study
  4. * Participant plans to move to another country within seven months

Contacts and Locations

Study Contact

Rachel Ruiz
CONTACT
913-945-5052
rruiz3@kumc.edu
Jaime Perales Puchalt, PhD, MPH
CONTACT
913-588-3716
jperales@kumc.edu

Principal Investigator

Jaime Perales Puchalt, PhD, MPH
PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center

Study Locations (Sites)

University of Kansas Medical Center
Fairway, Kansas, 66205
United States

Collaborators and Investigators

Sponsor: University of Kansas Medical Center

  • Jaime Perales Puchalt, PhD, MPH, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-02-17
Study Completion Date2029-05

Study Record Updates

Study Start Date2025-02-17
Study Completion Date2029-05

Terms related to this study

Additional Relevant MeSH Terms

  • Alzheimer Disease